Activation of fibroblast growth factor receptor 3 (FGFR3) has been reported to play important roles in several malignancies, including uterine cervix carcinoma and multiple myeloma as well as bladder cancers (BC)[1][2]. Here, FGFR3 is linked to cervical carcinoma.